The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation

Australasian Journal on Ageing

Volumn 21, Issue 1, 2002, Pages 36-41

  Krass, I ^a   Ogle, S J ^b   Duguid, M J ^b   Shenfield, G M ^b   Bajorek, Beata ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29244449925     PISSN: 14406381     EISSN: 17416612     Source Type: Journal    
DOI: 10.1111/j.1741-6612     Document Type: Article

References (27)

1. Lake FR, McCall MG, Cullen KJ, Rosman DL, de Klerk NH. Atrial fibrillation and mortality in an elderly population. Australian and New Zealand Journal of Medicine. 1989; 19: 321-326.
2. Wolf P, Abbott R, Kannel W. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Archives of Internal Medicine 1987; 147: 1561-1564.
3. Petersen P, Boysen G, Godtfredsen J, Andersen E, Andersen B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989; 1 ; 175-179.
4. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation New England Journal of Medicine 1990; 323: 1505-1511
5. Stroke Prevention in Atrial Fibrillation Investigators. The Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991; 84: 527-539.
6. Connolly S, Laupacis A, Gent M, Roberts R, Cairns J, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study, Journal of the American College of Cardiology 1991 ; 18: 349-355.
7. Ezekowitz M, Bridgers S, James K, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. New England Journal of Medicine 1992; 327: 1406-1412.
8. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Archives of internal Medicine 1994; 154: 1449-1457.
9. Bath P, Prasad A, Brown M. MacGregor G. Survey of use of anticoagulation in patients with atrial fibrillation. British Medical Journal 1993; 307: 1045.
10. National Centre for Classification in Health (NCCH). The International classification of diseases, ninth revision, Australian modification (ICD-9-AM). Sydney: Faculty of Health Sciences, University of Sydney, 1995.
11. SPSS Inc. Statistical Package for the Social Sciences. SPSS for Windows, Release 7.5.1 ed. Chicago: 1996
12. Ackerman R. Anticoagulation therapy in patients aged 80 years or more with atrial fibrillation: more caution is needed. Archives of Family Medicine 1995; 4: 1017-1026.
13. Lip G, Tean K, Dunn F. Treatment of atrial fibrillation in a district general hospital. British Heart Journal 1994; 71: 92-95.
14. Zarifis J, Beevers G, Lip G. Acute admissions with atrial fibrillation in a British multiracial hospital population. British Journal of Clinical Practice 1997; 51: 91-96.
15. Ang S, Peterson G, Friesen W, Vial J. Review of antithrombotic drug usage in atrial fibrillation. Journal of Clinical Pharmacy and Therapeutics 1998; 23: 97-106.
16. Mead G, Wardlwa J, Lewis S, McDowall M, Dennls M. The influence of randomized trials on the use of anticoagulants for atrial fibrillation. Age and Ageing 1999; 28: 441-446.
17. Stewart F, Singh Y, Persson S, Gamble G, Braatvedt G. Atrial fibrillation: prevalence and management in an acute general medical unit. Australian and New Zealand Journal of Medxine 1999; 29: 51-58.
18. Antani M, Beuth R, Covinsky K, et al. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation, Journal of General lnternal Medicine 1996; 11: 713-720.
19. Munschauer F, Priore R, Hens M, Castilone A. Thromboembolism prophylaxis in chronic atrial fibrillation: practice patterns in community and tertiary-care hospitals. Stroke 1997; 28: 72-76.
20. Sudlow C, Rodgers H, Kenny R, Thomson R. Service provision and use of anticoagulants in atrial fibrillation. British Medical Joumai 1995; 312: 175-178.
21. Ling O, Davies K, Slee A, Silas J. Atrial fibrillation in the elderly: physicians' attitudes in anticoagulation. British Journal of Clinical Practice 1995; 49: 123-125.
22. Lip G, Zarifis J, Watson R, Beevers D. Physician variation in the management of patients with atrial fibrillation. Heart 1996; 75: 200-205.
23. Kellen J, Russell M. Physician specialty is associated with differences in warfarin use for atrial fibrillation. Canadian Journal of Cardiology 1998; 14: 365-368.
24. McCrory D, Matchar O, Samsa G, Sanders L, Pritchett E. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Archives of lnternal Medicine 1995; 155:277-281.
25. Ezekowitz M, Levine J. Preventing stroke in patients with atrial fibrillation. Journal of the American Medical Association 1999; 281(19): 1830-1835.
26. Mant M. Can randomised trials inform clinical decisions about individual patients? Lancet 1999; 353: 743-746.
27. Bigby JD, Goldman L, et al. Assessing the preventability of emergency hospital admissions: a method for evaluating the quality of medical care in a primary care facility. American Journal of Medicine 1987; 83: 1031 -1 036.